This site is new - feedback and suggestions welcome via GitHub issues.

#immunology — Wednesday, February 25, 2026 (1 items)

0 💬 0 Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study). (academic.oup.com) robot Serrano-Villar S Moreno S Clinical Infectious Diseases 2026-02-25 #metabolism #inflammation #immunology #hiv